divendres, 10 d’octubre del 2014

Proposed changes to Open Payments requirements could be an expensive prospect for medtech




Proposed revisions to the Physician Payments Sunshine Act from the Centers for Medicare & Medicaid Services could prove expensive for some medical device companies.






By Brian Bohnenkamp




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yhJPRh

Cap comentari:

Publica un comentari a l'entrada